Abstract
Increased awareness of the effects on the central nervous system (CNS) of untreated hypertension has fostered a successful era of preventive medicine within neurology. The decline in mortality from stroke within the last decade is partly a result of early detection and treatment of hypertension. Conversely, the role of the CNS as a cause of hypertension is currently the focus of major research efforts in neuropharmacology. New classes and generations of antihypertensive drugs have been designed as a result of an increased understanding of the involvement of CNS in blood pressure control. One example is clonidine which, although initially developed as a nasal decongestant, has been successfully used as an antihypertensive and a pharmacological research tool. This paper will briefly review the role of the CNS in blood pressure control and the assessment of sympathetic neuronal function in man.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blessing WW, Chalmers JP (1979) Direct projections of catecholamine (presumably dopamine-containing) neurons from hypothalamus to spinal cord. Neurosci Lett 11: 35–40.
Chalmers JP, Reid JL (1972) Participation of central noradrenergic neurones in arterial baroreceptor reflexes in the rabbit. A study with intracisternally administered 6-hydroxydopamine Circ Res 31: 789–804.
Coote JH, MacLeod VH (1974) The influence of bulbospinal monoaminergic pathways on sympathetic nerve activity. J Physiol (Lond) 241: 453–475.
Dahlstrom A, Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbospinal neuron systems. Acta Physiol Scand 64 (Suppl 274): 1–36.
Dampney RAL (1981) Functional organization of central cardiovascular pathways. Clin Exp Pharmac Physiol 8: 241–259.
Day MD, Roach AG (1974) Central a-and ß-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats. Br J Pharmac 51: 325–333.
Diamond J (1955) Observations on the excitation by acetylcholine and by pressure of sensory receptors in the cat’s carotid sinus. J Physiol 130: 513–532.
Distler A, Philipp T (1980) Role of sympathetic nervous system in essential hypertension. Contrib Nephrol 23: 150–157.
Doba N, Reis DJ (1973) Acute fulminating neurogenic hypertension produced by brainstem lesions in the rat. Circ Res 32: 584–593.
Engelman K, Portnoy B, Sjoerdsma A (1970) Catecholamines — cyclic AMP-angiotension receptors. Plasma catecholamine concentrations in patients with hypertension. Circ Res 27 (Suppl 1): 141–146.
Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P (1981) Norepinephrine kinetics in essential hypertension: Defective neuronal uptake of norepinephrine in some patients. Hypertension 3: 149–156.
Eyzaguirre C, Lewin J (1961) Effect of different oxygen tensions on the carotid body in vitro. J Physiol 159: 238–250.
Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Kastner PR (1981) Blood pressure regulation: basic concepts. Fed Proc 40: 2252–2256.
Häusler G (1982) Central a-adrenoceptors involved in cardiovascular regulation. J Cardiovasc Pharmacol 4: S72 — S76.
Hilton SM, Spyer KM (1971) Participation of the anterior hypothalamus in the baroreceptor reflex. J Physiol 218: 271–293.
Hornbein TF, Griffo ZJ, Roos A (1961) Quantitation of chemoreceptor activity: interrelation of hypoxia and hypercapnia. J Neurophysiol 24: 561–568.
Humphrey DR (1967) Neuronal activity in the medulla oblongata of cat evoked by stimulation of the carotid sinus nerve. In: Kezdi P (ed.) Baroreceptors and Hypertension. Proceedings of International Symposium, Dayton, Ohio, 16–17 November 1965. Pergamon Press, Oxford, 131–168.
Isaac L (1980) Clonidine in the central nervous system: site and mechanism of hypotensive action. J Cardiovasc Pharmacol 2 (Suppl 1): S5 - S19.
Kopin IJ (1972) Metabolic degradation of catecholamines. The relative importance of different pathways under physiological conditions and after administration of drugs. Handbook Exp Pharmacol 33: 270–279.
Kopin IJ, Gordon EK, Jimerson DC, Polinsky RJ (1983) Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 219: 73–75.
Kopin IJ, Polinsky RJ, Oliver JA, Oddershede IR, Ebert MH (1983) Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension. J Clin Endocrinol Metab 57: 632–637.
Korner PI (1971) Integrative neural cardiovascular control. Physiol Rev 51: 312–367.
Kuhn DM, Wolf WA, Lovenberg W (1980) Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension 2: 243–255.
Lake CR, Gullner HG, Polinsky RJ, Ebert MH, Ziegler MG, Bartter FC (1981) Essential hypertension: central and peripheral norepinephrine. Science 211: 955–957.
Langer SZ (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol 60: 481–497.
Langer SZ, Massingham R, Shepperson NB (1981) ai-and a2-receptor subtypes: relevance to antihypertensive therapy. In: Buckley JP, Ferrario CM (eds) Central Nervou System Mechanisms in Hypertension, Perspectives in Cardiovascular Research, Vol. 6, Raven Press, New York, 161–170.
Loewy AD, Burton H (1978) Nuclei of the solitary tract: efferent projections to the lower brain stem and spinal cord of the cat. J Comp Neurol 181: 421–450.
Loewy AD, McKellar S (1980) The neuroanatomical basis of central cardiovascular control. Fed Proc 39: 2495–2503.
Mathias CJ, Frankel HL (1983) Autonomic failure in tetraplegia. In: Bannister R (ed.) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford, 453–488.
Muira M, Reis DJ (1969) Termination and secondary projections of carotid sinus nerve in the cat brain stem. Am J Physiol 217: 142–153.
Neumayr RJ, Hare BD, Franz DN (1974) Evidence for bulbospinal control of sympathetic pre-ganglionic neurones by monoaminergic pathways. Life Sci 14: 793–806.
Paintal AS (1963) Vagal afferent fibers. Ergeb Physiol Biol Chem Exp Pharmakol 52: 74–156.
Palkovits M (1981) Neuropeptides and biogenic amines in central cardiovascular control mechanisms. In: Buckley JP, Ferrario CM (eds) Central Nervous System Mechanisms in Hypertension. Perspectives in Cardiovascular Research, Vol. 6, Raven Press, New York, 73–87.
Palkovits M, Zaborsky L (1977) Neuroanatomy of central cardiovascular control. Nucleus tractus solitarii: afferent and efferent neuronal connections in relation to the baroreceptor reflex arc. In: Dejong W, Provoost AP, Shapiro AP (eds) Progress in Brain Research, Vol 47, Hypertension and Brain Mechanisms. Elsevier, Amsterdam, 9–34.
Polinsky RJ (1983) Pharmacologic responses and biochemical changes in progressive autonomic failure. In: Bannister R (ed) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford, 201–236.
Polinsky RJ, Kopin LJ, Ebert MH, Weise V (1981) Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 31: 1–7.
Polinsky RJ, Jimerson DC, Kopin IJ (1984) Chronic autonomic failure: CSF and plasma 3methoxy-4-hydroxyphenylglycol. Neurology (in press).
Przuntek H, Guimaraes S, Philippu A (1971) Importance of adrenergic neurons of the brain for a rise of blood pressure evoked by hypothalamic stimulation. Naunyn Schmiedebergs Arch Pharmacol 271: 311–319.
Reid JL (1983) Central and peripheral autonomic control mechanisms. In: Bannister R (ed.) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford University Press, Oxford, 17–35.
Robertson DL, Goldberg MR, Hollister AS, Wade D, Robertson RM (1983) Clonidine raises blood pressure in serve idiopathic orthostatic hypotension. Am J Med 74: 193–200.
Saran RK, Sahuja RC, Gupta NN, Hasan M, Bhargava KP, Shanker K, Kishor K (1978) 3-methoxy-4-hydroxyphenylglycol in cerebrospinal fluid and vanillylmandelic acid in urine of humans with hypertension Science 200: 317–318.
Spickler JW, Kezdi P, Geller E (1967) Transfer characteristics of the carotid sinus pressure control system. In: Kezdi P (ed) Baroreceptors and hypertension. Proceedings of International Symposium, Dayton, Ohio, 16–17 November 1965. Pergamon Press, Oxford, 31–40.
Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neurones of rat brain. Naunyn Schmiedeberg’s Arch Pharmacol 299: 123–141.
Tetsuo M, Polinsky RJ, Markey SP, Kopin IJ (1981) Urinary 6-hydroxymelatonin excretion in patients with orthostatic hypotension. J Clin Endocrinol Metab 53: 607–610.
Trendelenburg U (1963) Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 15: 225–276.
Wallin BG, Sundlöf G, Eriksson B-M, Dominiak P, Grobecker H, Lindblad L-E (1981) Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 111: 69–73.
Wikberg J (1978) Differentiation between pre-and postjunctional a-receptors in guinea pig ileum and rabbit aorta. Acta Physiol Scand 103: 225–239.
Young WS, Kuhar MJ (1980) Noradrenergic a,- and a2-receptors: light microscopic autoradiographic localization. Proc Natl Acad Sci USA 77: 1696–1700.
Ziegler MG, Lake CR, Kopin IJ (1977) The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 296: 293–297.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Polinsky, R.J. (1984). Central nervous system control of blood pressure. In: Weber, M.A., Mathias, C.J. (eds) Mild Hypertension. Steinkopff. https://doi.org/10.1007/978-3-642-85334-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-85334-0_2
Publisher Name: Steinkopff
Print ISBN: 978-3-642-85336-4
Online ISBN: 978-3-642-85334-0
eBook Packages: Springer Book Archive